New Treatments and Insights in MM: Equipping Nurses to Manage a Complex and Rapidly Evolving Disease

New Treatments and Insights in MM: Equipping Nurses to Manage a Complex and Rapidly Evolving Disease

Thursday, January 17, 2019 in Colorado Springs, CO
Private Event -- Paravicini's Italian Bistro, 6:30 PM MT
Frank Sinatra Room


  • Understanding the Latest Data and Indications in MM Care
  • Case Discussion
    • MM Diagnosis and Workup: Helping Patients Cope With Their Diagnosis and Understanding Their Treatment Plan
  • Patient Adherence Issues, Comorbidities, Frailties, and Psychosocial Issues
  • Strategies and Resources for Educating Patients and Their Families About Their Treatment Options at Each Stage of Disease
  • Putting It All Together: Take-away Resources and Discussion of Available Online Resources 


Kristi Kay Orbaugh, RN

Adult Oncology Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, Indiana

Sandra E. Kurtin, RN, MS, AOCN, ANP-C

Hematology/Oncology Nurse Practitioner
Clinical Assistant Professor of Nursing
Clinical Assistant Professor of Medicine
Arizona Cancer Center
University of Arizona
Tucson, Arizona

Goal Statement
The goal of this activity is to provide education and tools that help oncology nurses deliver optimal care for patients with multiple myeloma.

Target Audience 
This program is intended for oncology nurses and other allied health professionals who care for patients with multiple myeloma.

Learning Objectives 

  • Provide patient-focused education on the available clinical data and new therapeutic options for the individualized treatment of MM
  • Discuss with patients the available data and rationale for using monoclonal antibodies as well as new-generation immunomodulatory agents and proteasome inhibitors for individual patients with MM
  • Evaluate individualized treatment strategies for elderly patients through consideration of the available clinical data as well as risk assessment, comorbidities, and patient preferences
  • Develop a proactive management plan for adverse events associated with recently approved agents and novel combinations used to treat MM
  • Manage the physical, emotional, and social challenges experienced by patients diagnosed with MM through all stages of their disease


Nursing Continuing Education

Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation
1.0 contact hours may be earned for successful completion of this activity.

Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hours. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.

Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.